Editor's Choice - Carotid Stenosis Treatment: Variation in International Practice Patterns
M Venermo1, G Wang2, A Sedrakyan3
1University Hospital, Helsinki, Finland.
Summary
Treatment practices for carotid stenosis vary significantly worldwide, impacting patient demographics and intervention choices. Reimbursement models influence treatment rates for asymptomatic patients, highlighting a need for global guideline harmonization.
Area of Science:
- Vascular Surgery
- Health Services Research
- International Health
Background:
- Carotid stenosis management guidelines exist, yet international practice variations persist.
- Understanding current treatment patterns is crucial for improving patient outcomes.
Purpose of the Study:
- To assess current practices in treating carotid stenosis across 12 countries.
- To analyze variations in treatment modalities and patient demographics.
Main Methods:
- Utilized data from the US Vascular Quality Initiative (VQI) and Vascunet registry collaboration.
- Analyzed treatment variations for asymptomatic versus symptomatic patients between and within countries.
Main Results:
- Significant international and intra-country variations observed in patient demographics (age, sex) and treatment choices (carotid artery stenting).
- Countries with fee-for-service reimbursement showed higher treatment rates for asymptomatic patients.
- Proportion of asymptomatic patients treated varied widely, from 0% to 73% globally.
Conclusions:
- Current carotid stenosis treatment practices are inconsistent globally, influenced by reimbursement models.
- Existing guidelines may be inconsistently applied, necessitating international cooperation for standardization.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
354
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Mitral Stenosis III: Medical Management
390
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
390
Aneurysm III: Interprofessional Care
416
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
416
Peripheral Artery Disease III: Interprofessional Care
465
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
465
Angina IV: Management
368
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Atherosclerosis III: Management
538
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538


